Physician profile
May E Saif
NPI 1841834595
$2,536.05
in general payments reported to CMS, 2019-2025
15 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $920 · 2022: $282 · 2023: $592 · 2024: $484 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.51 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $552.93 | 2021-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $236.19 | 2021-2025 | Rexulti, Abilify Maintena |
| Lundbeck LLC | $227.84 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $219.82 | 2021-2024 | Caplyta |
| Neurocrine Biosciences, INC. | $194.40 | 2021-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $126.84 | 2024-2025 | Fanapt, Hetlioz |
| Teva Pharmaceuticals USA, INC. | $112.01 | 2023 | Austedo Xr, Austedo |
| Bausch Health US, LLC | $102.53 | 2021-2024 | Aplenzin, Wellbutrin |
| Axsome Therapeutics, INC. | $71.99 | 2023-2024 | Auvelity |
| Sunovion Pharmaceuticals INC. | $30.71 | 2022 | |
| Owp Pharmaceuticals, INC. | $20.62 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.09 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.69 | 2023 | Quviviq |
| Almatica Pharma LLC | $13.88 | 2025 | Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw May Saif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.